Daily non-political popular news in brief.

Older patients with major depression live longer with appropriate treatment, Penn study shows

Older patients with major depression whose primary care physicians team with depression care managers are 45 percent less likely to die within a five-year time period than older adults with major depression who receive their care in primary care practices where there are no depression care managers. This study, conducted by researchers at the University of Pennsylvania School of Medicine, appears in the current issue of the Annals of Internal Medicine.

Read more »

Keywords: older, patients, major, depression, live, longer, appropriate, treatment, penn, study, shows, patient, show

« Previous | Next »

Similar news on "Older patients with major depression live longer with appropriate treatment, Penn study shows":

1. Penn research shows transcranial magnetic stimulation effective in treating major depression
   11-26-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine and other study sites have found that transcranial magnetic stimulation -- a noninvasive technique that excites neurons in the brain via magnetic pulses passed through the scalp -- is a safe and effective, nondrug treatment with minimal side effects for patients with major depression who have tried other treatment options without benefit.
   Similar news · Read more »
   
2. From clinical cancer research: rethinking therapeutic cancer vaccine trials
   07-03-2007 · EurekAlert!
   Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
   Similar news · Read more »
   
3. Penn's Abramson Cancer Center part of major phase III study for myeloma
   11-21-2007 · EurekAlert!
   Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
   Similar news · Read more »
   
4. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
   12-20-2007 · EurekAlert!
   The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
   Similar news · Read more »
   
5. University of Colorado study shows intensive therapy helps in battle against bipolar disorder
   04-02-2007 · EurekAlert!
   New results from the largest federally funded bipolar study ever conducted show that patients who receive psychotherapy in addition to medication get better faster from bipolar disorder's debilitating depression and stay better longer, according to a University of Colorado at Boulder researcher involved in the study.
   Similar news · Read more »
   
6. Older men treated for early prostate cancer live longer than those who are not
   12-12-2006 · EurekAlert!
   Recent findings of an observational study by researchers at the University of Pennsylvania School of Medicine suggest that men between 65-80 years of age who received treatment for early stage, localized prostate cancer lived significantly longer than men who did not receive treatment. The study will be published in the Dec. 13 issue of JAMA.
   Similar news · Read more »
   
7. Rhode Island Hospital study confirms RF ablation effective for treating inoperable lung cancer
   03-27-2007 · EurekAlert!
   The overall results of a study of 153 patients with inoperable lung cancer show RF ablation to be safe and linked it with promising long-term survival and local tumor progression outcomes when compared to the older treatment method of external beam radiation (EBT). The study appears in the April issue of the journal Radiology.
   Similar news · Read more »
   
8. Analysis: Older men treated for early prostate cancer live longer than those not treated
   12-12-2006 · EurekAlert!
   An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
   Similar news · Read more »
   
9. Novel MS drug shows promise in 2 lethal leukemias
   08-28-2007 · EurekAlert!
   A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
   Similar news · Read more »
   
10. Patient navigators help minority, low-income cancer patients get life-saving treatments
    10-28-2007 · EurekAlert!
    Volunteers who guide low-income and minority cancer patients through cancer treatment, called lay patient navigators, help them to overcome major obstacles that prevent them from receiving quality care and achieving better outcomes, according to a study presented Oct. 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
    Similar news · Read more »